Abstract

How Flow Chemistry Can Impact the Early Drug Discovery Process?

Andrew Mansfield, Flow Chemistry Leader, Syrris

Flow chemistry is a growing technology in the pharma industry, where it has proved itself invaluable, especially in the process development phase of drug discovery. However, the hit-to-lead and lead-generation phases have been slower to embrace these techniques. The potential benefits are huge, particularly for rapid library generation and challenging chemistries that were previously hard to achieve by traditional batch methods. The content of this presentation looks at how researchers in early drug discovery, who are looking for practical and efficient ways to increase their productivity and shorten the hit-to-lead times can achieve this through the use of flow chemistry techniques.